Nutrien reported Q2 2026 adjusted EPS of $2.61, missing the revised consensus of $2.93, though sales of $10.812B exceeded estimates. Profitability was constrained by high sulfur costs and lower nitrogen volumes, despite record potash performance.

Nutrien reported Q2 2026 adjusted EBITDA of $2.4 billion, with H1 total rising 6% YoY to $3.5 billion. Potash sales volume guidance was raised to 14.2-14.8 million tons; capex guidance lowered by $50 million. Share repurchases accelerated to $75 million per month in Q3, up from ~$50 million per month earlier in the year. Retail H1 adjusted EBITDA grew 4% YoY to $1.24 billion, driven by proprietary products despite lower fertilizer volumes. The company generated ~$1 billion from asset divestitures since late 2024 and is reviewing strategic alternatives for its phosphate business.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Trump’s Belarus potash deal talk hit Mosaic (MOS) and Nutrien (NTR).

Kopernik Global Investors recently released its “Global All-Cap Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund faced a difficult investment environment in the second quarter of 2026, as momentum-driven markets and soaring semiconductor stocks sharply favored growth-oriented equities over the fund’s value-focused approach. Class I shares declined 6.60% […]

Nutrien Stock Recovers From a 5.2% Drop as Belarus Potash Deal Lacks Terms - TechStock²

Nutrien Ltd. coverage examines the latest Canadian market setting, its potash, nitrogen and agricultural inputs operations and the S&P/TSX 60 backdrop after Friday’s TSX session.

Dynamic Trading Report for Nutrien Ltd. (NTR) with Strategic Buy and Sell Signals

Nutrien Ltd. coverage examines current Canadian market conditions, its potash, nitrogen and agricultural inputs operations and the S&P/TSX 60 backdrop following the latest TSX session.

Public-market purchases continued as the stock traded below $100

Royal Bank Of Canada reissued an "outperform" rating and issued a $85.00 price objective on shares of Nutrien in a research note on Friday.